Varian Collaborates with BaraSeen Medical Company to Pave the Way for Advanced Cancer Treatment in Saudi Arabia with Sustainable Halcyon TechnologyApril 25, 2024
DECODE Group Successfully Secures U.S. Financial Services License, Strengthening Global Financial Market PositionApril 25, 2024
FDA approved lung cancer drug created by Mirati to cost $19,750 for 180 tablets Health December 13, 2022 The US Food and Drug Administration has approved Mirati Therapeutics Inc’s lung cancer drug Adagrasib, according to the company, sending…